With diabetes being a complex health condition, finding a cure for it naturally comes with quite a few challenges. However, scientists have recently made a huge breakthrough regarding the search for a cure by purging mice of the debilitating illness. This puts them one step closer to finally ending the suffering of thousands around the world who are living with diabetes every day.
Now, it’s worth noting that the study is still in its very early stages and there is still a lot of work to be done. However, it is encouraging to know that UT Health San Antonio researchers finally found a way to improve insulin secretion, which could potentially end insulin-dependency by diabetics, Futurism reports.
The researchers have tested their new method on lab mice that were afflicted with the disease and the rodents were cured. For one year, the subjects exhibited no symptoms to indicate that the cure did not work. Dr. Bruno Doiron, one of the researchers behind the project said as much.
“It worked perfectly,” Dr. Doiron said. “We cured mice for one year without any side effects. That’s never been seen. But it’s a mouse model, so caution is needed. We want to bring this to large animals that are closer to humans in physiology of the endocrine system.”
As a result, the researchers are now thinking about moving the cure to human trials over the next three years. That might seem like a lifetime, but it’s much closer than anyone has ever been to rid the world of diabetes.
It would seem that the obstacles won’t be much of an issue either since it would appear that the Food and Drug Administration has granted approval to similar cases in the past, News.com.au reports. If so, the world should be on track to becoming free of diabetes in the next decade or so.


NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 



